Robin Smith, MD
Dr. Smith, currently Chairman of the Board of Directors of Caladrius Biosciences (formerly NeoStem), was elevated to Executive Chairman of NeoStem in January 2015 after having previously served as Chairman and Chief Executive Officer of the company from 2006 to 2015. Leveraging her expertise in medicine and business development, Dr. Smith has positioned NeoStem as a leader in the emerging cellular therapy industry, built on a successful business model that combines a proprietary therapeutic development business and a successful contract development and manufacturing organization which provides services to others in the regenerative medicine industry. Dr. Smith earned her M.D. from Yale University and her M.B.A. from the Wharton School of Business.